このコンテンツを視聴するには、JoVE 購読が必要です。 サインイン又は無料トライアルを申し込む。
We demonstrate a step-by-step protocol for the investigation of gene function in peritoneal tissue-resident macrophages in vivo, using lentiviral vectors.
Peritoneal tissue-resident macrophages have broad functions in the maintenance of homeostasis and are involved in pathologies within local and neighboring tissues. Their functions are dictated by microenvironmental cues; thus, it is essential to investigate their behavior in an in vivo physiological niche. Currently, specific peritoneal macrophage-targeting methodologies employ whole-mouse transgenic models. Here, a protocol for effective in vivo modulation of mRNA and small RNA species (e.g., microRNA) expression in peritoneal macrophages using lentivirus particles is described. Lentivirus preparations were made in HEK293T cells and purified on a single sucrose layer. In vivo validation of lentivirus effectivity following intraperitoneal injection revealed predominant infection of macrophages restricted to local tissue. Targeting of peritoneal macrophages was successful during homeostasis and thioglycolate-induced peritonitis. The limitations of the protocol, including low-level inflammation induced by intraperitoneal delivery of lentivirus and time restrictions for potential experiments, are discussed. Overall, this study presents a quick and accessible protocol for the rapid assessment of gene function in peritoneal macrophages in vivo.
Tissue-resident macrophages (Mφ) are a heterogeneous population of phagocytic immune cells that sense and respond to invading pathogens1,2. In addition, they play an essential role in tissue development, remodeling, and maintaining homeostasis1,3. Many tissue Mφ derive from yolk sac progenitors during embryogenesis and persist in the tissue throughout the life4,5. The phenotype and functions of these cells are dictated by collaborative and hierarchical interactions of specific transcr....
All animal work was conducted in accordance with Institutional and UK Home Office guidelines.
NOTE: All in vivo studies with lentivirus should be performed according to local and national guidelines on the ethical use of animals in research, as well as adhering to all regulations associated with the use of category II infectious materials. Animal welfare should also be monitored in accordance with local regulations. In this step of the protocol, extreme care needs to be taken when wor.......
When followed fully and correctly, this protocol yields a total of 1.5 mL of high-quality lentivirus stock per single preparation, sufficient for twelve in vivo injections at the optimal volume determined in this study18. The success of the transfection can be evaluated early in the protocol. Healthy and confluent HEK293T cells should display, if present in the plasmids, an easily detectable marker signal (e.g., GFP used in this study) after 48 h post plasmid transfection (
Tissue-resident macrophages perform a range of homeostatic and inflammatory tissue-specific functions1,2 dictated by their physiological environment6,7,8,9. In this protocol, an effective method18 for manipulation of peritoneal resident macrophages in vivo using lentivirus particles was introduced to inv.......
This research was funded, in whole or in part, by the Wellcome Trust Investigator Award [107964/Z/15/Z]. P.R.T is also supported by the UK Dementia Research Institute. M.A.C is supported by the Biotechnology and Biological Sciences Research Council Discovery Fellowship (BB/T009543/1). For the purpose of Open Access, the author has applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission. L.C.D is a lecturer at Swansea University and an honorary research fellow at Cardiff University. This work is supported by work carried out by Ipseiz et al. 202018.
....Name | Company | Catalog Number | Comments |
0.05% Trypsin-EDTA (1x) (Trypsin 500 mg/L or 0.02 mM) | Thermo Fisher Scientific | 25300054 | |
0.22 μm sterile millex GP filter | Merck | SLGS033SS | |
0.45 μm sterile millex GP filter | Merck | SLHP033RS | |
0.5 mL U-100 insulin syringe with needle, 0.33 mm x 12.7 mm (29 G) | BD | 324892 | |
1 Litre Sharps Container | N/A | N/A | |
2.4G2 antibody (TruStain FcX anti-mouse CD16/32) | Biolegend | 101320 | |
40 μm strainer | Thermo Fisher Scientific | 22363547 | |
AimV medium (research grade), AlbuMax Supplement | Thermo Fisher Scientific | 31035025 | |
Blocking buffer | prepared in house | ||
Brewer thioglycolate medium | Sigma-Aldrich | B2551 | 4% stock solution prepared in water, autoclaved and kept frozen. |
CD11b | Biolegend | 101222 | Refer to Table 1 for the dilution and concentration |
CD11b | BD | 550993 | Refer to Table 1 for the dilution and concentration |
CD11c | Biolegend | 117317 | Refer to Table 1 for the dilution and concentration |
CD11c | Biolegend | 117333 | Refer to Table 1 for the dilution and concentration |
CD19 | BD | 560375 | Refer to Table 1 for the dilution and concentration |
CD19 | Biolegend | 152410 | Refer to Table 1 for the dilution and concentration |
CD226 | Biolegend | 128808 | Refer to Table 1 for the dilution and concentration |
CD3e | BD | 560527 | Refer to Table 1 for the dilution and concentration |
CD3e | Biolegend | 152313 | Refer to Table 1 for the dilution and concentration |
CD4 | Biolegend | 100412 | Refer to Table 1 for the dilution and concentration |
CD73 | eBioscience | 16-0731-82 | Refer to Table 1 for the dilution and concentration |
CD8a | eBioscience | 48-0081-82 | Refer to Table 1 for the dilution and concentration |
Cell culture flask (T175 fask, 175 cm2, 550 mL) | Greiner Bio One | 658175 | |
Centrifuge tubes, conical bottom tubes 25 mm x 89 mm | Beckman Coulter | 358126 | |
Centrifuges | Beckman Coulter | Ultracentrifuge and TC centrifuge | |
Collagenase type IV | Sigma-Aldrich | C5138 | |
Conical centrifuge tubes (15 mL and 50 mL) | Greiner Bio One | 11512303 & 11849650 | |
Cryotubes | Greiner Bio One | 123277 | or cryotubes |
DMEM medium (1x) + 4.5g/L D-glucose, 400 µM L-glutamine | Thermo Fisher Scientific | 41965-062 | |
Dnase I | Sigma-Aldrich | 11284932001 | |
Effectene transfection reagent | Qiagen | 301425 | |
F4/80 | Biolegend | 123123 | Refer to Table 1 for the dilution and concentration |
F4/80 | Biolegend | 123133 | Refer to Table 1 for the dilution and concentration |
F4/80 | Biolegend | 123147 | Refer to Table 1 for the dilution and concentration |
FceR1 | eBioscience | 48-5898-80 | Refer to Table 1 for the dilution and concentration |
Fetal calf serum (FCS) | Thermo Fisher Scientific | 10270-106 | heat inactivated for 30 min at 56 °C and sterile filtered through 0.22 μm filter |
Flow cytometer | Thermo Fisher Scientific | Attune NxT | |
Flow cytometry (FACS) buffer | prepared in house | ||
Fluorescent tissue culture microscope | Thermo Fisher Scientific | EVOS FL | |
Forceps | N/A | N/A | User preference |
Hank's balanced salt solution (HBSS) | Gibco, Life Technologies | 14175-053 | |
HEK293T cell line | grown for at least a week prior transfection. Mycoplasma free | ||
HIV-1 Core antigen | Beckman Coulter | 6604667 | |
Hyaluronidase | Sigma-Aldrich | H3506 | |
Hydrex surgical scrub, chlorhexiding gluconate 4% w/v skin cleanser | Ecolab | 3037170 | |
I-A/I-E | Biolegend | 107625 | Refer to Table 1 for the dilution and concentration |
ICAM1 | Becton Dickinson | 554970 | Refer to Table 1 for the dilution and concentration |
Jurkat T cell line | grown for at least a week prior use. Mycoplasma free | ||
LIVE/DEAD fixable near-IR dead cell stain kit | Thermo Fisher Scientific | L34975 | |
Ly6G | Biolegend | 127615 | Refer to Table 1 for the dilution and concentration |
Mice | here used C57BL/6 females, aged 8-12 weeks (Charles Rivers), unless specified differently | ||
Microcapillary pipettes (volume range 0.5-1,000 μL) | Fisher Scientific & Starlab | 11963466 & 11943466 & 11973466 & S1111-3700 | |
NK1.1 | Biolegend | 108724 | Refer to Table 1 for the dilution and concentration |
Paraformaldehyde | Sigma-Aldrich | P6148-500G | prepared to 2% w/v in PBS |
pCMV-ΔR8.91 packaging plasmid | Zuffrey, R., et al. 1997 | encodes Gag-Pol HIV protein driven by cytomegalovirus promoter. Ampicilin resistance. | |
Penicillin/Streptomycin (100x, 10,000 U/mL) | Thermo Fisher Scientific | 15140122 | |
Petri dish | Greiner Bio One | 664160 | |
pHR'SIN-cPPT-SEW plasmid | Rosas, M. et al. 2014 | modified for shRNA and miR expression studies. Encodes EGFP marker downstream SFFV promoter and upstream of the Woodchuck hepatitiv virus enhancer. Ampicilin resistance. | |
pMD2.G plasmid | Naldini, L. et al. 1996 | encodes vesicular stomatis virus g-glycoprotein (VSV-G) envelope. Ampicilin resistance. | |
Rat IgG1, κ isotype control | Becton Dickinson | 550617 | Refer to Table 1 for the dilution and concentration |
Rat serum | Sigma-Aldrich | R9759-10ML | |
Red blood ACK lysis buffer | prepared in house | ||
RPMI 1640 medium (1x) + 400 uM L-glutamine | Thermo Fisher Scientific | 21875-091 | |
Saponin | Sigma-Aldrich | S4521 | |
SiglecF | BD | 562681 | Refer to Table 1 for the dilution and concentration |
Sodium hypochlorite Tablets (bleach, 2,000 ppm) | Guest Medical | H8818 | |
Sterile 24-well cell culture plate | Greiner Bio One | 662160 | |
Sterile Dulbecco's PBS (DPBS) (1x) Mg++ and Ca2+ - free | Thermo Fisher Scientific | 14190144 | |
Sterile EDTA | Thermo Fisher Scientific | 15575020 | |
Sterile VWR disposable transfer pipets (23.0 mL, 30 cm) | VWR | 612-4515 | |
Sucrose | Thermo Fisher Scientific | 15503022 | |
surgical scissors | N/A | N/A | User preference |
Syringes (50 mL and 1 0mL) | Fisher Scientific | 10084450 & 768160 | |
Tim4 | Biolegend | 130007 | Refer to Table 1 for the dilution and concentration |
U-bottom 96-well cell culture plate | Greiner Bio One | 650180 |
This article has been published
Video Coming Soon
JoVEについて
Copyright © 2023 MyJoVE Corporation. All rights reserved